<DOC>
	<DOCNO>NCT01348789</DOCNO>
	<brief_summary>To measure safety hair removal device use frequently .</brief_summary>
	<brief_title>Safety Frequent Use Conditions Hair Removal Device</brief_title>
	<detailed_description>The primary endpoint study measure safety Hair2Go device use frequently . The secondary endpoint include kinetics hair clearance 8 week last treatment , gather information pain associate procedure</detailed_description>
	<criteria>Healthy male female , 18 65 year age . Willing sign inform consent . Willing follow treatment schedule post treatment followup . Willingness photograph treat area take may use marketing educational presentation and/or publication Willingness avoid excessive sun exposure two week prior treatment A history keloidal scarring ( hypertrophic scar keloid ) . Active dermatologic lesion infection treatment site . Subject permanent tattoo makeup treatment area . Recently tan area treat and/or unable unlikely refrain tan study . Subject disease related photosensitivity , porphyria , polymorphic light eruption , solar urticaria , lupus , etc Subject history herpes outbreak area treatment , unless receive preventative treatment physician Pregnant , plan become pregnant , hormone fluctuation and/or breast feeding experiment . Subjects Diabetes ( Type I II ) systemic metabolic condition Subject active electrical implant anywhere body , pacemaker , internal defibrillator , insulin pump , incontinence device , etc . Subject suffers epilepsy . Subject active cancer , history skin cancer cancer area treat , include presence malignant premalignant pigment lesion . Subject receive radiation therapy chemotherapy treatment past 3 month . Subject know anticoagulative thromboembolic condition form anticoagulation treatment . Subject history immunosuppressant/immune deficiency disorder ( include HIV infection AIDS ) currently use immunosuppressive medication . Subject condition physician 's opinion would make unsafe subject treat . Subject rotate type tweezer epilator treatment , wax within last 3 month Subject electrolysis treatment within last 6 month treatment area . Subject type professional intense pulse light ( IPL ) , laser RF hair removal treatment site within last 6 month . Participation study another device drug within 1 month prior enrollment study . Subject take medication know induce photosensitivity , include nonsteroidal antiinflammatory agent , tetracycline , phenothiazine , thiazide diuretic , sulfonylurea , sulfonamide , Dacarbazine ( DTIC ) , fluorouracil , vinblastine , griseofulvin within 4 week therapy . Subject take AccutaneÂ® within 6 month therapy . Subject steroid regimen last three month . Subject Gold therapy ( arthritis treatment ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Hair removal</keyword>
	<keyword>Hair Clearance</keyword>
	<keyword>Epilation</keyword>
</DOC>